Zantac sales stopped by Walgreens and CVS over carcinogenic fears

The Walgreens and CVS pharmacy chains have stopped selling heartburn medicine Zantac and its generic versions after the Food and Drug Administration warned this month that it had detected low levels of a carcinogenic drug in samples of the drug.

A Walgreens spokesman said in a statement Monday that the company had withdrawn the drug from its shelves "while the FDA continues its review of the products."

Walgreens and CVS, which announced the move on Saturday, both noted that the substance, known as ranitidine, has not been recalled. The companies said that customers who had purchased the products could return them for a refund.

F.D.A. has said that it is investigating the source of the contamination, as well as the risk to patients, and recommends that they talk to their doctors and that those who take a non-disk version consider switching to another medication.

Source link

Back to top button